Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate Nanoparticles for Severe COVID-19
NCT04352465Phase 2Unknown
- Sponsor
- Azidus Laboratories Limited
- Start
- May 2020
- Primary completion
- Jun 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methotrexate in coronavirus disease 2019 (COVID-19), acute respiratory distress syndrome (ARDS), sponsored by Azidus Laboratories Limited. Status: unknown.
02
Drugs
methotrexate
03
Conditions
coronavirus disease 2019 (COVID-19)acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT04352465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04352465.